Neuroinflammation and neovascularization in diabetic eye diseases (DEDs): identification of potential pharmacotherapeutic targets.

Panda, Siva Prasad; Reddy, P Hemachandra; Gorla, Uma Sankar; Prasanth, Dsnbk

Panda, Siva Prasad; Reddy, P Hemachandra; Gorla, Uma Sankar; Prasanth, Dsnbk.

Affiliation

Panda SP; Pharmacology Research Division, Institute of Pharmaceutical Research, GLA University, 281406, Mathura, Uttar Pradesh, India. sivaprasad.panda@gla.ac.in.
Reddy PH; Department of Internal Medicine, Texas Tech University Health Sciences Center, 79430, Lubbock, TX, USA.
Gorla US; Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, 79430, Lubbock, TX, USA.
Prasanth D; Department of Neurology, Texas Tech University Health Sciences Center, 79430, Lubbock, TX, USA.

Mol Biol Rep ; 50(2): 1857-1869, 2023 Feb.

Article in En | MEDLINE | ID: mdl-36513866

Subject(s)

Diabetes Mellitus; Diabetic Retinopathy; Humans; Aged; Vascular Endothelial Growth Factor A/metabolism; von Willebrand Factor/therapeutic use; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use; Neuroinflammatory Diseases; Programmed Cell Death 1 Receptor; Neovascularization, Pathologic/drug therapy; Vascular Endothelial Growth Factors; Diabetic Retinopathy/metabolism; Diabetes Mellitus/drug therapy

Key words

Blood retinal barrier; Diabetic retinopathy; FVIII/VWF/VEGF; Ocular angiosarcoma; PDL-1/PD-1; Retinoprotective drugs

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Diabetic Retinopathy Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Humans Language: En Journal: Mol Biol Rep Year: 2023 Type: Article Affiliation country: India

Fulltext

XML

PubMed Links

Search on Google